LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,254,607 | -24.0% | 438,161 | -8.6% | 2.24% | -10.5% |
Q2 2023 | $34,568,128 | -2.3% | 479,447 | -0.3% | 2.50% | -2.8% |
Q1 2023 | $35,368,162 | +109443.0% | 480,807 | -0.5% | 2.57% | +2.1% |
Q4 2022 | $32,287 | -99.9% | 483,347 | -1.6% | 2.52% | -25.1% |
Q3 2022 | $42,289,000 | -4.4% | 491,107 | -1.0% | 3.37% | +1.8% |
Q2 2022 | $44,255,000 | -23.0% | 496,028 | -2.9% | 3.31% | -3.2% |
Q1 2022 | $57,464,000 | -28.3% | 510,843 | -1.6% | 3.41% | -25.7% |
Q4 2021 | $80,162,000 | +2.0% | 518,988 | -8.0% | 4.60% | +0.4% |
Q3 2021 | $78,625,000 | +0.8% | 564,349 | -5.1% | 4.58% | +9.6% |
Q2 2021 | $77,976,000 | -4.8% | 594,380 | +10.7% | 4.18% | -6.8% |
Q1 2021 | $81,869,000 | +28.2% | 537,028 | -16.4% | 4.48% | +16.2% |
Q4 2020 | $63,854,000 | +1.0% | 642,073 | -3.2% | 3.85% | -9.4% |
Q3 2020 | $63,233,000 | -12.7% | 663,383 | +2.4% | 4.25% | -18.1% |
Q2 2020 | $72,441,000 | +56.7% | 647,668 | +1.9% | 5.19% | +31.7% |
Q1 2020 | $46,232,000 | – | 635,758 | – | 3.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $8,459 | 3.32% |
VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |